Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Insightrx, Ortho Clinical, Pillar, Zoll.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abcentra, Aimmune, Beyondspring, Cytomx, Effector, Enzyvant, Humanigen, Inovio, Nordic Nanovector, Pfizer, Pharmaxis.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Avacta Group, Electrocore, Fio, Mel-Mont Medical, Mighty Oak Medical, Neuropace, Orthopediatrics, Relay Medical, Speedx.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abl, Advita, Aldeyra, Arcturus, Bausch, BMS, CSL, Cytodyn, Marinus, Medexus, Moderna, Monopar, Novartis, Panther, Pharmather, Relief, Roche, UCB.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allegro, Ambrx, Angion, Antibe, Eli Lilly, Evotec, Fate, Jacobio, Janssen, Kiniksa, Lumosa, Lutris, Rhythm, Springworks.
Investigators at the University of California at San Francisco have identified a confounder that appears to be behind the purported anti-SARS-CoV-2 effects of a number of therapeutic candidates that were identified via repurposing.
LONDON – The U.K. has set up the first randomized controlled trial of COVID-19 vaccines in pregnant women, to assess different dosing schedules. The aim is to find the balance between longer intervals that are known to spur a greater immune response, against shorter intervals that provide faster protection.
RSS
